Thales Unveils Data Risk Intelligence to Redefine Data Risk Visibility and Proactive Risk Mitigation
Data Risk Intelligence combines posture and behaviour-based data risk indicators to proactively identify and mitigate risks to sensitive data First solution uniting the data security capabilities from the Imperva Data Security Fabric and Thales CipherTrust Data Security Platforms to provide highly confident data risk prioritisation with clear corrective actions for CIOs, CISOs, and data risk specialists
Thales today announced the launch of Data Risk Intelligence, a groundbreaking Imperva Data Security Fabric (DSF) solution that proactively addresses the risks to data wherever it resides. This is the first solution uniting the risk and threat identification capabilities of the Imperva Data Security Fabric with the data protection capabilities of the Thales CipherTrust Data Security Platform, following Thales’s strategic acquisition of Imperva in December 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203485067/en/
In today’s modern digital landscape, organisations face challenges in managing security across an ever-growing attack surface while maintaining compliance with regulatory standards. With data and operations spread across cloud, on-premises and hybrid systems, security teams require constant, comprehensive visibility into where their data is, the types of data they have, and the potential risks to that data. In fact, according to the 2024 Thales Data Threat Report, 93% of enterprises reported an increase in threats compared to the previous year.
Empowering Security Teams and SOCs with Enhanced Visibility and Control
The combined intelligence and contextual insights from Data Risk Intelligence provide a unified visibility of risks to critical data with a unique view of the strength of encryption for data across an organisation’s entire data estate. With this enhanced visibility, Data Risk Intelligence empowers CIOs, CISOs, and data risk specialists to accurately identify the most critical data that are at risk by severity and likelihood, enabling them to effectively prioritise risk mitigation with clear recommendations for corrective action.
Data Risk Intelligence delivers a highly confident risk score and clear recommendations for corrective action that are based on a wide-ranging set of data risk indicators through advanced analytics, built upon user permissions, data source vulnerabilities, use of encryption following NIST standards, monitoring of suspicious activities, and other customisable inputs.
Todd Moore, Vice President, Data Security products at Thales: “The ability to view data risk in key dimensions across organisational risk, asset risk, and regulatory risk in one place is extremely impactful. Data Risk Intelligence is the first of many integrations between the Thales and Imperva platforms that empower our customers to protect their data and all the paths to it. Through our combined platforms, Thales has all the tools to help our customers understand their data security risks and provide a clear set of actions to mitigate these risks.”
“The risks to enterprise data are multi-dimensional and organisations are struggling to address the volume and breadth of these risks while still maintaining optimal business operations,” said Jennifer Glenn, Research Director, Data and Information Security at IDC Security and Trust Group. “Centralising data risk visibility and management offers valuable context about the data – and it’s vulnerabilities – enabling organisations to prioritise protection where it’s needed most.”
Key Benefits of Data Risk Intelligence:
- Enhanced Risk Prioritisation: Combines risk-related intelligence from Data Security Fabric and CipherTrust Data Security Platform to deliver precise risk scores that drive confident decisions.
- Comprehensive Visibility: Provides a unified view of data risks across the entire data estate, reducing complexity, delivering risk indicators, and recommending protective measures.
- Customisable Risk Indicators: Allows organisations to tailor risk indicators to their specific environment, highlighting the most critical threats.
- Encryption Integration: Leverages the encryption capabilities of the CipherTrust Data Security Platform to ensure data protection at all levels.
- Advanced Analytics: Utilises posture-based and machine-learning behavioural risk indicators to identify and prioritise the highest-risk data.
DSF Data Risk Intelligence is available to customers who have a current Data Security Fabric Data 360 license.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies specialized in three business domains: Defence & Security, Aeronautics & Space, and Cyber & Digital.
It develops products and solutions that help make the world safer, greener and more inclusive.
The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G.
Thales has close to 81,000 employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.
PLEASE VISIT
Cloud Protection & Licensing Solutions | Thales Group
Cybersecurity Solutions | Thales Group
View source version on businesswire.com: https://www.businesswire.com/news/home/20241203485067/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press release
Ranks 125th Among 500 Companies Around the GlobeTop 10% in the Environmental Sector Among 3,000 Major Global Companies Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 10
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press release
Agreement Marks Significant Step Towards Increasing Italy’s Contribution to advancing Lunar Exploration ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom